Petitioner Manohar Lal Sharma, an advocate, sought direction to order closure of Ranbaxy manufacturing units located in Ponta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh and other places under Section 18 the Drugs and Cosmetics Act 1947.

Seeking direction to the Central Bureau of Investigation to initiate a probe into the alleged supply of sub-standard medicines and proceed against all the former and the present directors of Ranbaxy, the public interest litigation sought directions to restrain the drug manufacturing company from marketing its medicines in India.